Latest Research in CRISPR and Genetic Engineering
29 research papers · 2026 median publication year
Top Research Topics in CRISPR and Genetic Engineering
- CRISPR and Genetic Engineering — 6 papers
- Protein Degradation and Inhibitors — 5 papers
- interferon and immune responses — 2 papers
- RNA modifications and cancer — 2 papers
- Virus-based gene therapy research — 2 papers
- Hepatitis B Virus Studies — 1 papers
- Inflammasome and immune disorders — 1 papers
- DNA Repair Mechanisms — 1 papers
- Polyamine Metabolism and Applications — 1 papers
- Pluripotent Stem Cells Research — 1 papers
Highest-Cited Papers
- Ubiquitin receptor–mediated, ubiquitin-independent targeted protein degradation via 26 S proteasomes
- Resolution of viral R-loop by DHX9 promotes hepatitis B virus replication
- Hsc70-Mediated Targeting Chimeras for Targeted Protein Degradation via Chaperone-Mediated Autophagy
- Cyclosporin A triggers a RIG-I-mediated interferon response through multiple cellular processes
- Coronavirus Nsp5‑mediated dual‑site cleavage of GSDMA modifies its antiviral and proinflammatory functions
- Detection and sequencing of Ap 2 N-capped RNAs in human cells
- Supramolecular Degraders: An Emerging Paradigm in Targeted Protein Degradation
- Leveraging high-throughput proteomics and AI-based protein folding to accelerate VAV1 molecular glue discovery
- Rewriting the cancer epigenome: CRISPR technologies for DNA methylation editing
- Structural Signatures of the O6-Methylguanine Lesion: A Multi-Method Feature Selection Analysis of Molecular Dynamics Simulations
- Polyamines as emerging regulators of RNA biology: linking the epitranscriptome, translation, hypusination and post-transcriptional gene regulation
- MiniSdd7‐Derived Cytosine Base Editor Promotes Efficient Multiplex Gene Knockout in Porcine Primary Fibroblasts
- Minimal CBX3-Derived UCOE Confers Long-Term Resistance to Transgene Silencing in Human iPSCs During Neuronal Differentiation
- EGFR-Degrading PROTACs and Calcium Peroxide Co-loaded Liposomes: Enabling EGFR Degradation and Hypoxia Alleviation as Dual Safeguards for NSCLC Therapy.
- A Single-Administration AAV Gene Therapy Expressing an Affinity-Detuned Feline AIM (m-fAIM) for Chronic Kidney Disease in the Domestic Cat: A Theoretical Development Program
- A Single-Administration AAV Gene Therapy Expressing an Affinity-Detuned Feline AIM (m-fAIM) for Chronic Kidney Disease in the Domestic Cat: A Theoretical Development Program
- Thermodynamic and Statistical Signatures of Modality Changes in Concentration Distributions Driven by Stochastic Switching Between Two Activity States
- Transient Expression of an IL-1Ra−Fc Fusion Cytokine in Tobacco Species for Improved Anti-inflammatory Therapeutic Potential
- Modulation of Host Cell Death Signaling Platforms by Plasmodium falciparum: Implications for Eryptosis Regulation and Parasite Survival
- The inspiration of CRISPR-Cas: Interface of nature with a pharmacy: A compatible horizon of cancer treatment